No CrossRef data available.
Article contents
Prevalence of insulin resistance and diabetes mellitus type II in bipolar disorders
Published online by Cambridge University Press: 23 March 2020
Abstract
Bipolar disorder (BD) is associated with high morbidity and mortality. Patients are symptomatic almost half of their lives and experience significant disability. One subtype of BD is associated with a more chronic course, refractoriness to treatment and poor outcome. Diabetes mellitus type 2 (T2D) and insulin resistance (IR) have been identified as risk factors for this more severe form of BD.
We investigated the rates of IR and T2D in patients with BD and whether this comorbidity is associated with specific clinical features of BD such as rapid cycling or treatment resistance.
IR and T2D were screened in patients with BD types I or II, who were on stable treatment with mood stabilizers. The response to treatment was assessed by means of the Alda scale.
In a preliminary sample, we made a new diagnosis of IR in 40% of patients. The 1% of this sample had a diagnosis of T2D. The treatment response was worse in BD patients with comorbid IR or T2D as compared to those without metabolic abnormalities.
These findings show that IR and T2D have high prevalence in BD patients and have negative impact on treatment response.
The authors have not supplied their declaration of competing interest.
- Type
- EV213
- Information
- European Psychiatry , Volume 33 , Issue S1: Abstracts of the 24th European Congress of Psychiatry , March 2016 , pp. S341
- Copyright
- Copyright © European Psychiatric Association 2016
Comments
No Comments have been published for this article.